Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 9 studies | 35% ± 19% | |
| GABAergic neuron | 7 studies | 42% ± 17% | |
| oligodendrocyte | 6 studies | 24% ± 6% | |
| endothelial cell | 5 studies | 24% ± 9% | |
| epithelial cell | 5 studies | 33% ± 11% | |
| retinal cone cell | 5 studies | 28% ± 12% | |
| astrocyte | 5 studies | 24% ± 7% | |
| oligodendrocyte precursor cell | 5 studies | 25% ± 8% | |
| interneuron | 5 studies | 49% ± 21% | |
| neuron | 4 studies | 25% ± 7% | |
| retinal rod cell | 4 studies | 23% ± 5% | |
| retinal bipolar neuron | 3 studies | 27% ± 9% | |
| GABAergic interneuron | 3 studies | 26% ± 6% | |
| fibroblast | 3 studies | 20% ± 1% | |
| basal cell | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1148.12 | 1444 / 1445 | 100% | 8.80 | 183 / 183 |
| brain | 100% | 1422.57 | 2634 / 2642 | 100% | 5.75 | 705 / 705 |
| breast | 100% | 1089.24 | 459 / 459 | 100% | 7.72 | 1114 / 1118 |
| ovary | 100% | 1435.68 | 180 / 180 | 100% | 4.75 | 428 / 430 |
| prostate | 100% | 1362.47 | 245 / 245 | 99% | 5.56 | 499 / 502 |
| thymus | 100% | 1573.62 | 653 / 653 | 99% | 4.96 | 600 / 605 |
| stomach | 100% | 1049.86 | 358 / 359 | 99% | 7.95 | 284 / 286 |
| bladder | 100% | 1135.62 | 21 / 21 | 99% | 5.71 | 499 / 504 |
| intestine | 100% | 1178.22 | 966 / 966 | 99% | 6.67 | 521 / 527 |
| uterus | 100% | 1386.61 | 170 / 170 | 99% | 5.23 | 453 / 459 |
| pancreas | 100% | 1065.03 | 327 / 328 | 99% | 4.31 | 176 / 178 |
| kidney | 100% | 804.89 | 89 / 89 | 98% | 5.10 | 881 / 901 |
| lung | 97% | 882.02 | 560 / 578 | 100% | 6.14 | 1155 / 1155 |
| adrenal gland | 100% | 1241.28 | 257 / 258 | 97% | 3.65 | 223 / 230 |
| skin | 100% | 1892.17 | 1806 / 1809 | 88% | 4.32 | 417 / 472 |
| liver | 99% | 672.42 | 224 / 226 | 88% | 2.53 | 358 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 4.76 | 29 / 29 |
| spleen | 100% | 1199.35 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 5.21 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.47 | 1 / 1 |
| adipose | 100% | 963.53 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 868.10 | 1326 / 1335 | 0% | 0 | 0 / 0 |
| heart | 95% | 640.22 | 815 / 861 | 0% | 0 | 0 / 0 |
| muscle | 94% | 445.61 | 751 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 58% | 866.26 | 542 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 53% | 1.33 | 42 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1990481 | Biological process | mRNA pseudouridine synthesis |
| GO_0001522 | Biological process | pseudouridine synthesis |
| GO_0006397 | Biological process | mRNA processing |
| GO_0005634 | Cellular component | nucleus |
| GO_0009982 | Molecular function | pseudouridine synthase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | PUS7L |
| Protein name | Pseudouridylate synthase PUS7L (EC 5.4.99.-) (Pseudouridylate synthase 7 homolog-like protein) Alternative protein PUS7L Pseudouridine synthase 7 like |
| Synonyms | |
| Description | FUNCTION: Pseudouridine synthase that catalyzes pseudouridylation of mRNAs. . |
| Accessions | F8VP66 ENST00000431332.7 [Q9H0K6-2] F8VW99 L8EB78 F8VWC0 ENST00000553166.1 ENST00000550784.5 ENST00000416848.6 [Q9H0K6-1] ENST00000344862.10 [Q9H0K6-1] ENST00000549868.1 F8VZA0 ENST00000551923.5 [Q9H0K6-1] ENST00000547156.1 Q9H0K6 |